These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 18784153

  • 1. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
    Abraham D.
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153
    [Abstract] [Full Text] [Related]

  • 2. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 3. RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production.
    Li G, Li D, Xie Q, Shi Y, Jiang S, Jin Y.
    J Gene Med; 2008 Sep; 10(9):1039-47. PubMed ID: 18613219
    [Abstract] [Full Text] [Related]

  • 4. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
    Shiwen X, Leask A, Abraham DJ, Fonseca C.
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743
    [Abstract] [Full Text] [Related]

  • 5. Connective tissue growth factor and cardiac fibrosis.
    Daniels A, van Bilsen M, Goldschmeding R, van der Vusse GJ, van Nieuwenhoven FA.
    Acta Physiol (Oxf); 2009 Mar; 195(3):321-38. PubMed ID: 19040711
    [Abstract] [Full Text] [Related]

  • 6. [Transforming growth factor-beta and its receptors in scleroderma].
    QIAN H, ZHENG M.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
    [Abstract] [Full Text] [Related]

  • 7. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
    Ishibuchi H, Abe M, Yokoyama Y, Ishikawa O.
    Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
    [Abstract] [Full Text] [Related]

  • 8. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.
    Gressner OA, Gressner AM.
    Liver Int; 2008 Sep; 28(8):1065-79. PubMed ID: 18783549
    [Abstract] [Full Text] [Related]

  • 9. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.
    Hemmatazad H, Rodrigues HM, Maurer B, Brentano F, Pileckyte M, Distler JH, Gay RE, Michel BA, Gay S, Huber LC, Distler O, Jüngel A.
    Arthritis Rheum; 2009 May; 60(5):1519-29. PubMed ID: 19404935
    [Abstract] [Full Text] [Related]

  • 10. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis.
    Arai M, Ikawa Y, Chujo S, Hamaguchi Y, Ishida W, Shirasaki F, Hasegawa M, Mukaida N, Fujimoto M, Takehara K.
    J Dermatol Sci; 2013 Mar; 69(3):250-8. PubMed ID: 23142052
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
    Qi W, Chen X, Poronnik P, Pollock CA.
    Int J Biochem Cell Biol; 2008 Mar; 40(1):9-13. PubMed ID: 17300978
    [Abstract] [Full Text] [Related]

  • 12. Connective tissue growth factor: context-dependent functions and mechanisms of regulation.
    Cicha I, Goppelt-Struebe M.
    Biofactors; 2009 Mar; 35(2):200-8. PubMed ID: 19449449
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.
    Leask A.
    Keio J Med; 2004 Jun; 53(2):74-7. PubMed ID: 15247510
    [Abstract] [Full Text] [Related]

  • 14. [Connective tissue growth factor (CTGF): a key factor in the onset and progression of kidney damage].
    Sánchez-López E, Rodrigues Díez R, Rodríguez Vita J, Rayego Mateos S, Rodrigues Díez RR, Rodríguez García E, Lavoz Barria C, Mezzano S, Egido J, Ortiz A, Ruiz-Ortega M, Selgas R.
    Nefrologia; 2009 Jun; 29(5):382-91. PubMed ID: 19820749
    [Abstract] [Full Text] [Related]

  • 15. Animal models of scleroderma: lessons from transgenic and knockout mice.
    Derrett-Smith EC, Denton CP, Sonnylal S.
    Curr Opin Rheumatol; 2009 Nov; 21(6):630-5. PubMed ID: 19730378
    [Abstract] [Full Text] [Related]

  • 16. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis.
    Ikawa Y, Ng PS, Endo K, Kondo M, Chujo S, Ishida W, Shirasaki F, Fujimoto M, Takehara K.
    J Cell Physiol; 2008 Sep; 216(3):680-7. PubMed ID: 18481257
    [Abstract] [Full Text] [Related]

  • 17. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo.
    Sisco M, Kryger ZB, O'Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, Roy NK, Dean NM, Mustoe TA.
    Wound Repair Regen; 2008 Sep; 16(5):661-73. PubMed ID: 19128261
    [Abstract] [Full Text] [Related]

  • 18. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G, Vetuschi A, Sferra R, Catitti V, D'Angelo A, Zanninelli G, Flanders KC, Gaudio E.
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [Abstract] [Full Text] [Related]

  • 19. Effect of transforming growth factor-beta1 on expression of the connective tissue growth factor (CCN2/CTGF) gene in normal human gingival fibroblasts and periodontal ligament cells.
    Takeuchi H, Kubota S, Murakashi E, Fukada T, Hashimoto S, Takigawa M, Numabe Y.
    J Periodontal Res; 2009 Apr; 44(2):161-9. PubMed ID: 19210343
    [Abstract] [Full Text] [Related]

  • 20. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
    Iannone F, Matucci-Cerinic M, Falappone PC, Guiducci S, Cinelli M, Distler O, Lapadula G.
    J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.